Industry Research Reports

Home > Reports > Chemical & Material > Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 97 Pages

Report ld: 3475986

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hirudin Market Size(US$)

CAGR 2025-2031

3.1%

Market Size,2031

USD 5,214

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,341 million

Market Forecast in 2031(Value)

US$ 5,214 million

CAGR

3.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

This report aims to provide a comprehensive presentation of the global market for Hirudin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hirudin by region & country, by Type, and by Application.

The Hirudin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.

MARKET SEGMENTATION

By Company

The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Natural Hirudin
Recombinant Hirudin

Segment by Application

Thrombosis Disease
Tumor Disease
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Hirudin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Hirudin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Hirudin Product Introduction

1.2 Global Hirudin Market Size Forecast

1.2.1 Global Hirudin Sales Value (2020-2031)

1.2.2 Global Hirudin Sales Volume (2020-2031)

1.2.3 Global Hirudin Sales Price (2020-2031)

1.3 Hirudin Market Trends & Drivers

1.3.1 Hirudin Industry Trends

1.3.2 Hirudin Market Drivers & Opportunity

1.3.3 Hirudin Market Challenges

1.3.4 Hirudin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hirudin Players Revenue Ranking (2024)

2.2 Global Hirudin Revenue by Company (2020-2025)

2.3 Global Hirudin Players Sales Volume Ranking (2024)

2.4 Global Hirudin Sales Volume by Company Players (2020-2025)

2.5 Global Hirudin Average Price by Company (2020-2025)

2.6 Key Manufacturers Hirudin Manufacturing Base and Headquarters

2.7 Key Manufacturers Hirudin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hirudin

2.9 Hirudin Market Competitive Analysis

2.9.1 Hirudin Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Hirudin Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Natural Hirudin

3.1.2 Recombinant Hirudin

3.2 Global Hirudin Sales Value by Type

3.2.1 Global Hirudin Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Hirudin Sales Value, by Type (2020-2031)

3.2.3 Global Hirudin Sales Value, by Type (%) (2020-2031)

3.3 Global Hirudin Sales Volume by Type

3.3.1 Global Hirudin Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Hirudin Sales Volume, by Type (2020-2031)

3.3.3 Global Hirudin Sales Volume, by Type (%) (2020-2031)

3.4 Global Hirudin Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Thrombosis Disease

4.1.2 Tumor Disease

4.1.3 Others

4.2 Global Hirudin Sales Value by Application

4.2.1 Global Hirudin Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Hirudin Sales Value, by Application (2020-2031)

4.2.3 Global Hirudin Sales Value, by Application (%) (2020-2031)

4.3 Global Hirudin Sales Volume by Application

4.3.1 Global Hirudin Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Hirudin Sales Volume, by Application (2020-2031)

4.3.3 Global Hirudin Sales Volume, by Application (%) (2020-2031)

4.4 Global Hirudin Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Hirudin Sales Value by Region

5.1.1 Global Hirudin Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Hirudin Sales Value by Region (2020-2025)

5.1.3 Global Hirudin Sales Value by Region (2026-2031)

5.1.4 Global Hirudin Sales Value by Region (%), (2020-2031)

5.2 Global Hirudin Sales Volume by Region

5.2.1 Global Hirudin Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Hirudin Sales Volume by Region (2020-2025)

5.2.3 Global Hirudin Sales Volume by Region (2026-2031)

5.2.4 Global Hirudin Sales Volume by Region (%), (2020-2031)

5.3 Global Hirudin Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Hirudin Sales Value, 2020-2031

5.4.2 North America Hirudin Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Hirudin Sales Value, 2020-2031

5.5.2 Europe Hirudin Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Hirudin Sales Value, 2020-2031

5.6.2 Asia Pacific Hirudin Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Hirudin Sales Value, 2020-2031

5.7.2 South America Hirudin Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hirudin Sales Value, 2020-2031

5.8.2 Middle East & Africa Hirudin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hirudin Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Hirudin Sales Value

6.2.1 Key Countries/Regions Hirudin Sales Value, 2020-2031

6.2.2 Key Countries/Regions Hirudin Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Hirudin Sales Value, 2020-2031

6.3.2 United States Hirudin Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Hirudin Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Hirudin Sales Value, 2020-2031

6.4.2 Europe Hirudin Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Hirudin Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Hirudin Sales Value, 2020-2031

6.5.2 China Hirudin Sales Value by Type (%), 2024 VS 2031

6.5.3 China Hirudin Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Hirudin Sales Value, 2020-2031

6.6.2 Japan Hirudin Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Hirudin Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Hirudin Sales Value, 2020-2031

6.7.2 South Korea Hirudin Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Hirudin Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Hirudin Sales Value, 2020-2031

6.8.2 Southeast Asia Hirudin Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Hirudin Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Hirudin Sales Value, 2020-2031

6.9.2 India Hirudin Sales Value by Type (%), 2024 VS 2031

6.9.3 India Hirudin Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 The Medicines Company

7.1.1 The Medicines Company Company Information

7.1.2 The Medicines Company Introduction and Business Overview

7.1.3 The Medicines Company Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 The Medicines Company Hirudin Product Offerings

7.1.5 The Medicines Company Recent Development

7.2 Keyken

7.2.1 Keyken Company Information

7.2.2 Keyken Introduction and Business Overview

7.2.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Keyken Hirudin Product Offerings

7.2.5 Keyken Recent Development

7.3 Minapharm

7.3.1 Minapharm Company Information

7.3.2 Minapharm Introduction and Business Overview

7.3.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Minapharm Hirudin Product Offerings

7.3.5 Minapharm Recent Development

7.4 Abbott

7.4.1 Abbott Company Information

7.4.2 Abbott Introduction and Business Overview

7.4.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Abbott Hirudin Product Offerings

7.4.5 Abbott Recent Development

7.5 SALUBRIS

7.5.1 SALUBRIS Company Information

7.5.2 SALUBRIS Introduction and Business Overview

7.5.3 SALUBRIS Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 SALUBRIS Hirudin Product Offerings

7.5.5 SALUBRIS Recent Development

7.6 Pfizer, Inc

7.6.1 Pfizer, Inc Company Information

7.6.2 Pfizer, Inc Introduction and Business Overview

7.6.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Pfizer, Inc Hirudin Product Offerings

7.6.5 Pfizer, Inc Recent Development

7.7 Teva Pharmaceutical Industries Ltd

7.7.1 Teva Pharmaceutical Industries Ltd Company Information

7.7.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview

7.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Teva Pharmaceutical Industries Ltd Hirudin Product Offerings

7.7.5 Teva Pharmaceutical Industries Ltd Recent Development

7.8 DUOPUTAI

7.8.1 DUOPUTAI Company Information

7.8.2 DUOPUTAI Introduction and Business Overview

7.8.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 DUOPUTAI Hirudin Product Offerings

7.8.5 DUOPUTAI Recent Development

7.9 Pentapharm

7.9.1 Pentapharm Company Information

7.9.2 Pentapharm Introduction and Business Overview

7.9.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Pentapharm Hirudin Product Offerings

7.9.5 Pentapharm Recent Development

8 Industry Chain Analysis

8.1 Hirudin Industrial Chain

8.2 Hirudin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hirudin Sales Model

8.5.2 Sales Channel

8.5.3 Hirudin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Hirudin Market Trends

Table 2. Hirudin Market Drivers & Opportunity

Table 3. Hirudin Market Challenges

Table 4. Hirudin Market Restraints

Table 5. Global Hirudin Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Hirudin Revenue Market Share by Company (2020-2025)

Table 7. Global Hirudin Sales Volume by Company (2020-2025) & (K MT)

Table 8. Global Hirudin Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Hirudin Price by Company (2020-2025) & (USD/MT)

Table 10. Key Manufacturers Hirudin Manufacturing Base and Headquarters

Table 11. Key Manufacturers Hirudin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hirudin

Table 13. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hirudin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Hirudin Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Hirudin Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Hirudin Sales Market Share in Value by Type (2020-2025)

Table 20. Global Hirudin Sales Market Share in Value by Type (2026-2031)

Table 21. Global Hirudin Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)

Table 22. Global Hirudin Sales Volume by Type (2020-2025) & (K MT)

Table 23. Global Hirudin Sales Volume by Type (2026-2031) & (K MT)

Table 24. Global Hirudin Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Hirudin Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Hirudin Price by Type (2020-2025) & (USD/MT)

Table 27. Global Hirudin Price by Type (2026-2031) & (USD/MT)

Table 28. Global Hirudin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Hirudin Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Hirudin Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Hirudin Sales Market Share in Value by Application (2020-2025)

Table 32. Global Hirudin Sales Market Share in Value by Application (2026-2031)

Table 33. Global Hirudin Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)

Table 34. Global Hirudin Sales Volume by Application (2020-2025) & (K MT)

Table 35. Global Hirudin Sales Volume by Application (2026-2031) & (K MT)

Table 36. Global Hirudin Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Hirudin Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Hirudin Price by Application (2020-2025) & (USD/MT)

Table 39. Global Hirudin Price by Application (2026-2031) & (USD/MT)

Table 40. Global Hirudin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Hirudin Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Hirudin Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Hirudin Sales Value by Region (2020-2025) & (%)

Table 44. Global Hirudin Sales Value by Region (2026-2031) & (%)

Table 45. Global Hirudin Sales Volume by Region (K MT): 2020 VS 2024 VS 2031

Table 46. Global Hirudin Sales Volume by Region (2020-2025) & (K MT)

Table 47. Global Hirudin Sales Volume by Region (2026-2031) & (K MT)

Table 48. Global Hirudin Sales Volume by Region (2020-2025) & (%)

Table 49. Global Hirudin Sales Volume by Region (2026-2031) & (%)

Table 50. Global Hirudin Average Price by Region (2020-2025) & (USD/MT)

Table 51. Global Hirudin Average Price by Region (2026-2031) & (USD/MT)

Table 52. Key Countries/Regions Hirudin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Hirudin Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Hirudin Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Hirudin Sales Volume, (2020-2025) & (K MT)

Table 56. Key Countries/Regions Hirudin Sales Volume, (2026-2031) & (K MT)

Table 57. The Medicines Company Company Information

Table 58. The Medicines Company Introduction and Business Overview

Table 59. The Medicines Company Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 60. The Medicines Company Hirudin Product Offerings

Table 61. The Medicines Company Recent Development

Table 62. Keyken Company Information

Table 63. Keyken Introduction and Business Overview

Table 64. Keyken Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 65. Keyken Hirudin Product Offerings

Table 66. Keyken Recent Development

Table 67. Minapharm Company Information

Table 68. Minapharm Introduction and Business Overview

Table 69. Minapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 70. Minapharm Hirudin Product Offerings

Table 71. Minapharm Recent Development

Table 72. Abbott Company Information

Table 73. Abbott Introduction and Business Overview

Table 74. Abbott Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 75. Abbott Hirudin Product Offerings

Table 76. Abbott Recent Development

Table 77. SALUBRIS Company Information

Table 78. SALUBRIS Introduction and Business Overview

Table 79. SALUBRIS Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 80. SALUBRIS Hirudin Product Offerings

Table 81. SALUBRIS Recent Development

Table 82. Pfizer, Inc Company Information

Table 83. Pfizer, Inc Introduction and Business Overview

Table 84. Pfizer, Inc Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 85. Pfizer, Inc Hirudin Product Offerings

Table 86. Pfizer, Inc Recent Development

Table 87. Teva Pharmaceutical Industries Ltd Company Information

Table 88. Teva Pharmaceutical Industries Ltd Introduction and Business Overview

Table 89. Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 90. Teva Pharmaceutical Industries Ltd Hirudin Product Offerings

Table 91. Teva Pharmaceutical Industries Ltd Recent Development

Table 92. DUOPUTAI Company Information

Table 93. DUOPUTAI Introduction and Business Overview

Table 94. DUOPUTAI Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 95. DUOPUTAI Hirudin Product Offerings

Table 96. DUOPUTAI Recent Development

Table 97. Pentapharm Company Information

Table 98. Pentapharm Introduction and Business Overview

Table 99. Pentapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 100. Pentapharm Hirudin Product Offerings

Table 101. Pentapharm Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Hirudin Downstream Customers

Table 105. Hirudin Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Hirudin Product Picture

Figure 2. Global Hirudin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Hirudin Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Hirudin Sales Volume (2020-2031) & (K MT)

Figure 5. Global Hirudin Sales Price (2020-2031) & (USD/MT)

Figure 6. Hirudin Report Years Considered

Figure 7. Global Hirudin Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Hirudin Players Sales Volume Ranking (2024) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hirudin Revenue in 2024

Figure 10. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Natural Hirudin Picture

Figure 12. Recombinant Hirudin Picture

Figure 13. Global Hirudin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Hirudin Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Hirudin Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)

Figure 16. Global Hirudin Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Hirudin Price by Type (2020-2031) & (USD/MT)

Figure 18. Product Picture of Thrombosis Disease

Figure 19. Product Picture of Tumor Disease

Figure 20. Product Picture of Others

Figure 21. Global Hirudin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Hirudin Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Hirudin Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)

Figure 24. Global Hirudin Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Hirudin Price by Application (2020-2031) & (USD/MT)

Figure 26. North America Hirudin Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Hirudin Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Hirudin Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Hirudin Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Hirudin Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Hirudin Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Hirudin Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Hirudin Sales Volume (%), (2020-2031)

Figure 38. United States Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 44. China Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 46. China Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 56. India Hirudin Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Hirudin Sales Value by Type (%), 2024 VS 2031

Figure 58. India Hirudin Sales Value by Application (%), 2024 VS 2031

Figure 59. Hirudin Industrial Chain

Figure 60. Hirudin Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Hirudin in 2025? shouQi

Which companies rank high in the global Hirudin market? shouQi

What was the global market size of Hirudin in 2031? shouQi

What is the annual compound growth rate of the global Hirudin market size from 2025 to 2031? shouQi

Related Reports

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 150
USD 2900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 3950.00
(Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 180
USD 4900.00
(Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 142
USD 3950.00
(Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 180
USD 4900.00
(Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 106
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 114
USD 2900.00
(Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published Date: 2024-04-17
Pages: 154
USD 5600.00
(Single User License)

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 150
USD 2900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
USD 3950.00 (Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 180
USD 4900.00 (Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 142
USD 3950.00 (Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 180
USD 4900.00 (Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 106
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 114
USD 2900.00 (Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published: 2024-04-17
Pages: 154
USD 5600.00 (Single User License)